Howlader N, Noone AM, Krapcho M, et al. (eds). SEER Cancer Statistics Review, 1975-2014, National Cancer Institute.
Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 2017
Looking for non-cell indicators of real-time changes in gene expression, immune activity, and proteins.
Intelligent model decomposes complex genomic, proteomic, and metabolomic datasets to reveal clinically actionable insights.
Our multidimensional tools show the relatedness between subgroups of healthy and diseased individuals and the latter's shared aberrations.